Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 3/20 | 0.39 |
| ▸ | PRKCA | P17252 | 4/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL379498 | 0.98 | NPSR1 (0.40) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL9355913 | 0.98 | NPSR1 (0.38) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL13601677 | 0.95 | NPSR1 (0.37) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL373323 | 0.95 | NPSR1 (0.39) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL14840402 | 0.95 | NPSR1 (0.39) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL7565413 | 0.95 | NPSR1 (0.39) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL1310194 | 0.93 | NAAA (0.41) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL537284 | 0.92 | NPSR1 (0.39) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL537285 | 0.90 | MAPT (0.34) | NPSR1MAPTMAPK1L3MBTL1NAAA | |
| SCHEMBL13601679 | 0.90 | NPSR1 (0.40) | NPSR1MAPTMAPK1L3MBTL1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4434747-A2 | RESIN MOLDED PRODUCT, LAMINATE, AND DECORATIVE SHEET | TOPPAN PRINTING CO., LTD. (JP) | 2024-09-25 | — | — | EP | disclosed |
| EP-3632978-B1 | RESIN MOLDED BODY, LAMINATE AND DECORATIVE SHEET | TOPPAN PRINTING CO LTD (JP) | 2024-08-14 | — | — | EP | disclosed |
| US-11021598-B2 | Resin molded product, laminate, and decorative sheet | TOPPAN PRINTING CO., LTD. (JP) | 2021-06-01 | — | — | US | disclosed |
| EP-3632978-A1 | RESIN MOLDED BODY, LAMINATE AND DECORATIVE SHEET | Toppan Printing Co., Ltd. (JP) | 2020-04-08 | — | — | EP | disclosed |
| US-20200048445-A1 | RESIN MOLDED PRODUCT, LAMINATE, AND DECORATIVE SHEET | TOPPAN PRINTING CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
| US-9951205-B2 | Stable compositions of thiabendazole and iodine-containing fungicides | LANXESS DEUTSCHLAND GMBH (DE) | 2018-04-24 | — | — | US | disclosed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | disclosed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | disclosed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-07-30 | — | — | US | disclosed |
| US-20090036555-A1 | Stabilization of iodine biocides | LANXESS DEUTSCHLAND GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1993362-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | Lanxess Deutschland GmbH & Co.KG (DE) | 2008-11-26 | — | — | EP | disclosed |
| US-20080039585-A1 | Thermosetting Resin Composition, Thermosetting Film, Cured Product of Those, and Electronic Component | JSR CORPORATION (JP) | 2008-02-14 | — | — | US | disclosed |
| WO-2007101549-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-13 | — | — | WO | disclosed |
| EP-1454956-B1 | EPOXY RESIN COMPOSITION EXCELLENT IN WEATHER RESISTANCE AND FIBER-REINFORCED COMPOSITE MATERIALS | TORAY INDUSTRIES (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-20050191476-A1 | Epoxy resin composition excellent in weather resistance and fiber-reinforced composite materials | TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) | 2005-09-01 | — | — | US | disclosed |
| US-6902811-B2 | Epoxy resin composition excellent in weather resistance and fiber-reinforced composite materials | TORAY INDUSTRIES, INC. (JP) | 2005-06-07 | — | — | US | disclosed |
| EP-1454956-A1 | EPOXY RESIN COMPOSITION EXCELLENT IN WEATHER RESISTANCE AND FIBER-REINFORCED COMPOSITE MATERIALS | TORAY INDUSTRIES, INC. (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-20040031952-A1 | Expoxy resin composition excellent in weather resistance and fiber-reinforced composite materials | TORAY INDUSTRIES, INC. (JP) | 2004-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036555-A1 | Stabilization of iodine biocides | LCT, BTD, HDHD5 | NPSR1 2958/4885MAPT 592/4885MAPK1 4846/4885 |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LCT, BTD, ALKBH3 | NPSR1 3008/4885MAPT 666/4885MAPK1 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.